- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Nath Bio-Genes (India) Limited has submitted the Compliance Certificate for the quarter ended 31st December 2024, as required by SEBI regulations. This certificate confirms that the securities received for dematerialization during the quarter have been verified and processed appropriately.
The timely compliance with these regulatory requirements enhances transparency and operational efficiency, which is positive for the company's governance profile. For investors, this demonstrates Nath Bio-Genes' commitment to adhering to industry standards, potentially fostering a favorable outlook while ensuring shareholder interests are well-managed amid operational procedures.